CAHIR AI

Startup

Cahir Solutions helps biotech and digital health teams turn AI‑ and data‑driven concepts into compliant, commercially ready SaMD and connected medical products through integrated regulatory, product, and go‑to‑market strategy, supported with custom AI tools. Our MedCompass AI-assisted regulatory products support clients and stakeholders in their innovation journey toward successful payer and market adoption with speed and precision.  We help innovators move from a model where post market surveillance is a compliance obligation that runs parallel to product development — to one where PMS is a continuous intelligence feed within an integrated system of intelligence tools that makes every next-generation product safer, more effective, and faster to market. 

Our team of experts offer clients with 40 plus years of successful client engagement experience and we support clients with a full device lifecycle development activities including SaMD and medical device classification and pathway strategy, IMDRF/FDA‑aligned evidence planning, IEC 62304/ISO 13485‑aligned development frameworks, and evidence-based approaches to clinical evaluation, post‑market surveillance, and change management for AI/ML‑enabled products.

At BioTech X 2026, we are particularly focused on helping biotech and life sciences organizations translate cutting‑edge data science, genomics, and AI research into compliant, scalable digital products that generate clinical and commercial value. Whether you are an early‑stage team considering your first SaMD concept or an established biotech expanding into digital diagnostics and decision support, Cahir Solutions brings hands-on experience, clear communication, and actionable playbooks to align science, software, and regulation from day one.

Currently, we are innovating in the home device space with the FDA on innovative SaMDs, helping hospital‑at‑home programs with enhancing transparency, safety and quality of data sharing, continuous monitoring and improving patient care post hospital discharge to reduce readmission rates.